XML 63 R25.htm IDEA: XBRL DOCUMENT
v3.21.2

Stock Award Plans | 12 Months Ended
--- | ---
Sep. 30, 2021
Share-based Payment Arrangement [Abstract] |
Stock Award Plans | STOCK AWARD PLANS The Company's stock based compensation plan provides for grants of stock options and restricted stock. On January 22, 2020, the shareholders approved the 2020 Incentive Plan. Upon approval of the 2020 Incentive Plan, the 2011 Incentive Plan terminated with respect to future awards, and the remaining shares that were not awarded under the 2011 Incentive Plan as of that date were canceled. A total of 3,200,000 shares are available for grant under the 2020 Incentive Plan and 2,318,974 shares remain available for issuance as of September 30, 2021. When applicable, stock options are granted with an exercise price equal to the market price of the Company's stock at the date of grant; those option awards generally vest based on three to five years of continuous service and have 10-year contractual terms. The Company's policy is to issue new shares upon option exercises. The fair value of stock options granted is estimated on the date of grant using the Black-Scholes option-pricing model. Additionally, there may be other factors that would otherwise have a significant effect on the value of employee stock options granted but are not considered by the model. Expected volatility is based on the historical volatility of the Company's stock. The risk-free interest rate is based on the U.S. Treasury yield curve that is in effect at the time of grant with a remaining term equal to the options' expected life. The expected term represents the period of time that options granted are expected to be outstanding. Stock Option Awards: There were no stock options granted under the incentive plans during 2021, compared to 1,043,349 stock options granted in 2020 and 356,343 stock options granted in 2019 under the previous plan. A summary of stock option activity and changes during the year are as follows.
Options | Number of Options | Weighted Average Exercise Price | Weighted Average Remaining Contractual Term (Years) | Aggregate Intrinsic Value (In thousands)
Outstanding at September 30, 2019 | 320,287 |  | $ | 27.21 |  | 8 | $ | 3,136 |
Granted | 1,043,349 |  | 29.53 |  |  |
Exercised | (8,085) |  | 17.88 |  |  |
Forfeited | (125,827) |  | 30.25 |  |  |
Outstanding at September 30, 2020 | 1,229,724 |  | 28.93 |  | 9 | — |
Granted | — |  | — |  |  |
Exercised | (19,846) |  | 17.06 |  |  |
Forfeited | (179,555) |  | 29.05 |  |  |
Outstanding at September 30, 2021 | 1,030,323 |  | $ | 29.14 |  | 8 | $ | 5,330 |
Exercisable at September 30, 2021 | — |  | $ | — |  | 0 | $ | — |
The table below presents other information regarding stock options.
Year ended September 30, | 2021 | 2020 | 2019
| (In thousands, except grant date fair value per stock option)
Compensation cost for stock options | $ | 1,676 |  | $ | 1,344 |  | $ | 521 |
Weighted average grant date fair value per stock option | 4.39 |  | 4.37 |  | 5.21 |
Total intrinsic value of options exercised | 276 |  | 102 |  | 414 |
Grant date fair value of options exercised | 78 |  | 33 |  | 51 |
Cash received from option exercises | 339 |  | 144 |  | 298 |
The following is a summary of activity related to unvested stock options.
Year ended September 30, | 2021 |  | 2020 |  | 2019
Unvested Stock Options | Options Outstanding | Weighted Average Grant Date Fair Value |  | Options Outstanding | Weighted Average Grant Date Fair Value |  | Options Outstanding | Weighted Average Grant Date Fair Value
Outstanding at beginning of period | 1,210,689 |  | $ | 4.38 |  |  | 293,167 |  | $ | 5.33 |  |  | — |  | $ | — |
Granted | — |  | — |  |  | 1,043,349 |  | 4.17 |  |  | 356,343 |  | 5.33 |
Vested | — |  | — |  |  | — |  | — |  |  | — |  | — |
Forfeited | (179,555) |  | 4.31 |  |  | (125,827) |  | 4.83 |  |  | (63,176) |  | 5.33 |
Outstanding at end of period | 1,031,134 |  | $ | 4.39 |  |  | 1,210,689 |  | $ | 4.38 |  |  | 293,167 |  | $ | 5.33 |
As of September 30, 2021, there was $1,527,457 of unrecognized compensation cost related to stock options. Restricted Stock Awards: The Company grants shares of restricted stock pursuant to the incentive plans. The restricted stock grants are subject to a service condition and vest over a period of one to seven years. Certain grants of restricted stock to executive officers are also subject to additional market and performance conditions based upon meeting certain total shareholder return targets pre-established by the Board. The Company had a total of 522,991 shares of restricted stock outstanding as of September 30, 2021, with a total grant date fair value of $10,438,900. The following table summarizes information about unvested restricted stock activity.
Year ended September 30, | 2021 |  | 2020 |  | 2019
Non-vested Restricted Stock | Outstanding | Weighted Average Fair Value |  | Outstanding | Weighted Average Fair Value |  | Outstanding | Weighted Average Fair Value
Outstanding at beginning of period | 409,469 |  | $ | 24.32 |  |  | 435,838 |  | $ | 23.73 |  |  | 460,999 |  | $ | 22.52 |
Granted | 331,344 |  | 17.04 |  |  | 197,706 |  | 26.24 |  |  | 249,272 |  | 21.41 |
Vested | (132,649) |  | 30.64 |  |  | (205,715) |  | 25.56 |  |  | (159,103) |  | 26.09 |
Forfeited | (85,173) |  | 12.94 |  |  | (18,360) |  | 17.20 |  |  | (115,330) |  | 10.61 |
Outstanding at end of period | 522,991 |  | $ | 19.96 |  |  | 409,469 |  | $ | 24.32 |  |  | 435,838 |  | $ | 23.73 |
Compensation expense related to restricted stock awards was $4,473,000, $4,453,000, and $4,188,000 for the years ended 2021, 2020 and 2019, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration